4893 items matching your search terms.

The clinical value of metabolic syndrome and its components in established type 2 diabetes mellitus: the FIELD trial

O'Brien, R Scott, R Best, J Taskinen, MR Pardy, C Ehnholm, C Keech, A FIELD Study Investigators,

The relationship between the development of rash and clinical and quality of life outcomes in colorectal cancer patients treated with cetuximab in NCIC–CTC CO.17

O'Callaghan, CJ Tu, D Karapetis, CS Au, HJ Moore, MJ Zalcberg, JR Trudeau, M Yip, D Vachan, B Jonker, DJ

The relationship between proteinuria and coronary risk: a systematic review and meta-analysis

Perkovic, V. Verdon, C. Ninomiya, T. Barzi, F. Cass, A. Patel, A. Jardine, M. Gallagher, M. Turnbull, F. Chalmers, J. Craig, J. Huxley, R.
PLOS MEDICINE, 2008     DOI:10.1371/journal.pmed.0050207

Safety analysis of an international multi-centre randomised phase II–III study of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer: AGITG MAX trial

Price, TJ Gebski, V van Hazel, G. Robinson, B Broad, A Ganju, V. Chua, Y Wilson, K Tunney, V Tebbutt, N.

International multi-centre randomised phase II-III study of capecitabine, bevacizumab and mitomycin C as first-line treatment for metastatic colorectal cancer: final safety analysis of the AGITG MAX trial.

Price, TJ Gebski, V van Hazel, G Robinson, B Broad, A Ganju, V Chua, Y Wilson, K Tunney, V Tebbutt, N.

AGITG MAX trial—capecitabine, bevacizumab, and mitomycin C in metastatic colorectal cancer: safety analysis of 400 patients in an international multi-centre randomized phase II–III study

Price, TJ Gebski, V van Hazel, G Robinson, B Broad, A Ganju, V Chua, Y Wilson, K Tunney, V Tebbutt, N

Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumors. An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate

Sciot, R Debiec-Rychter, M Daugaard, S Fisher, C Collin, F Van Glabbeke, M Verweij, J Blay, J-Y Hogendoorn, PCW on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group and the Australian Trials Group,

Influence of the way results are presented on research interpretation and medical decision making: the PRIMER Collaboration randomized studies

Shakespeare, TP Gebski, V Tang, J Lim, K Lu, JJ Xiaojian, Z Guoliang, J
MEDICAL DECISION MAKING, 2008     DOI:10.1177/0272989x07309640

Effects Of fenofibrate on cardiovascular events in patients with type 2 diabetes mellitus after adjustment for statin use and other drugs: the FIELD study

Simes, J Voysey, M O’Connell, R Best, J Scott, R Glasziou, P Pardy, C Byth, K Keech, A on behalf of the FIELD study investigators,

Assembling the evidence for new cancer staging tests: a systematic review of positron emission tomography in patients with colorectal liver metastases

Staub, LP Dyer, SM Lord, SJ

Positron emission tomography for head and neck cancer

Staub, L McIsaac, M Wortley, S Dyer, S Marinovich, L Medical Services Advisory Committee,

Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study

Stewart, RAH; North, FM; Sharples, KJ; Simes, RJ; Tonkin, AM; White, HD; for the LIPID study investigators,

Comparing utilities for advanced colorectal cancer valued from societal and cancer-patients’ perspectives using baseline data from the MAX study of the Australasian Gastro-Intestinal Trials Group

Stockler, M Grimison, P Price, T van Hazel, G Wilson, K Tunney, V Tebbutt, N

First-event or marginal estimation of cause-specific hazards for analysing correlated multivariate failure-time data?

Tai, BC De Stavola, BL de Gruttola, V Gebski, V Machin, D

ATTAX2—docetaxel plus cetuximab as second-line treatment for docetaxel refractory oesophago-gastric cancer: final results of a multi-center phase II trial by the AGITG

Tebbutt, NC Sourjina, T Strickland, AH Van Hazel, G Pavlakis, N Ganju, V Murone, C MacGregor, D Gebski, V Cummins, M